鹭燕医药(002788) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 2,335,647,706.20, representing a year-on-year growth of 25.71%[8] - Net profit attributable to shareholders increased by 32.68% to CNY 32,092,929.94 for the period[8] - Basic earnings per share rose by 31.58% to CNY 0.25[8] - The weighted average return on net assets was 2.25%, up from 0.42% in the previous year[8] - The company expects net profit attributable to shareholders for 2017 to range from ¥115.53 million to ¥150.18 million, representing a growth of 0.00% to 30.00% compared to ¥115.52 million in 2016, driven by acquisitions and sales growth[19] Asset and Liability Changes - Total assets increased by 51.34% to CNY 5,314,071,915.63 compared to the end of the previous year[8] - Accounts receivable balance increased by 60.76% to ¥2,518.30 million, primarily due to sales growth in Fujian Province and acquisitions outside Fujian contributing ¥392.22 million, accounting for 41.21% of the increase[16] - Prepayments increased by 71.74% to ¥201.08 million, driven by supplier requirements for prepayment in Fujian and acquisitions adding ¥70.10 million, which made up 83.46% of the increase[16] - Inventory balance rose by 55.14% to ¥1,160.08 million, influenced by increased sales in Fujian and acquisitions contributing ¥151.24 million, representing 36.68% of the increase[16] - Short-term borrowings surged by 125.90% to ¥2,036.22 million, reflecting increased funding needs due to acquisitions outside Fujian[16] - Goodwill increased by 461.81% to ¥158.07 million, primarily due to acquisitions outside Fujian adding ¥1,299.31 million in goodwill[16] - Other receivables rose by 38.67% to ¥134.57 million, with acquisitions contributing ¥33.84 million, accounting for 90.19% of the increase[16] - Fixed assets increased by 31.67% to ¥427.43 million, with acquisitions adding ¥71.41 million, which accounted for 69.46% of the increase[16] - Other payables increased by 1,106.94% to ¥347.27 million, with acquisitions contributing ¥302.97 million, making up 95.12% of the increase[16] Cash Flow - The net cash flow from operating activities was negative at CNY -139,988,434.25, a decline of 213.43% compared to the previous year[8] - The company received cash related to operating activities amounting to ¥89.72 million, a 271.69% increase year-on-year, driven by acquisitions outside Fujian[17] Shareholder Information - The total number of shareholders at the end of the reporting period was 24,530[12] - The largest shareholder, Xiamen Maidi Ken Technology Co., Ltd., holds 35.21% of the shares, amounting to 45,125,000 shares[12] - The company did not engage in any repurchase transactions during the reporting period[13] Research and Development - The company established the "Fujian Province Kangyuan Image Intelligent Research Institute" with an investment of CNY 3 million to focus on artificial intelligence technology research[9]